Share Price and Basic Stock Data
Last Updated: December 4, 2025, 12:51 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Dharani Sugars & Chemicals Ltd has faced significant challenges in its operational performance over recent years. The company reported a total sales figure of only ₹1 lakh for March 2023, a sharp decline from ₹524 Cr in March 2014. This downward trend continued, with sales standing at ₹0 for the subsequent fiscal years up to March 2025, indicating severe operational disruptions. The last reported revenue from operations was negligible, contributing to a trailing twelve months (TTM) revenue of just ₹2 lakh. Such drastic reductions in sales reflect a systemic issue within the company, potentially linked to market conditions or internal inefficiencies. The operating profit margin (OPM) for March 2023 was recorded at -1,127%, further emphasizing the company’s struggle to generate profit from its activities. The absence of consistent revenue generation raises concerns about the sustainability of its business model and its ability to recover in a competitive landscape.
Profitability and Efficiency Metrics
The profitability metrics for Dharani Sugars & Chemicals Ltd paint a troubling picture. The company reported a net profit of -₹31 lakh for March 2023, which turned into a remarkable profit of ₹121 lakh for March 2024, before plunging back into the red with a net profit of -₹93 lakh for March 2025. The fluctuations indicate a volatile operational performance, with the interest coverage ratio (ICR) standing at -0.49x for March 2025, highlighting the company’s inability to meet its interest obligations. The return on capital employed (ROCE) stood at -17.01% for the same period, significantly below the typical sector average of around 8-15%, which raises red flags about operational efficiency. Additionally, the cash conversion cycle has been reported at an alarming -302,768 days for March 2023, indicating severe liquidity issues. These metrics underline the company’s struggle to maintain profitability and operational efficiency, posing significant risks to its financial health.
Balance Sheet Strength and Financial Ratios
Dharani Sugars & Chemicals Ltd’s balance sheet reflects considerable financial distress. As of March 2025, the company’s borrowings stood at ₹489 Cr against reserves of -₹205 Cr, indicating a negative net worth situation, which is a significant concern for creditors and investors alike. The total liabilities were reported at ₹471 Cr, with total assets of ₹471 Cr, implying that the company is effectively operating at a break-even point. The financial ratios further illustrate the precarious position; the current ratio was a mere 0.03x, suggesting severe liquidity issues compared to the industry standard of around 1.5-2.0x. The negative book value per share of -₹39.33 for March 2025 further underscores the negative equity status of the company. Such financial metrics could deter potential investors and raise questions about the viability of future operations unless significant restructuring occurs.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Dharani Sugars & Chemicals Ltd reveals a concentrated ownership structure, with promoters holding 61.55% of the equity as of March 2025. This indicates a strong control by the founding members, which can be a double-edged sword; while it can provide stability and continuity, it can also limit external influence and governance. Institutional investors appear to have negligible interest, with domestic institutional investors (DIIs) holding just 0.01%, and foreign institutional investors (FIIs) not reported. This lack of institutional backing may signal low investor confidence in the company’s future prospects. The number of shareholders has also seen a decline from 19,761 in December 2022 to 19,399 in September 2025, suggesting a potential exit of retail investors amid the company’s financial instability. Overall, the shareholding dynamics reflect caution and skepticism among the investment community regarding the company’s recovery trajectory.
Outlook, Risks, and Final Insight
The outlook for Dharani Sugars & Chemicals Ltd remains uncertain and fraught with challenges. The company’s inability to generate consistent revenue and maintain profitability poses a significant risk to its sustainability. Key strengths include the existing promoter stake, which could facilitate decision-making for potential turnaround strategies, and the company’s assets that could be leveraged if operational issues are resolved. However, the risks are substantial, including persistent liquidity issues, high debt levels, and a lack of institutional investor confidence. In scenarios where the company can successfully restructure its operations and improve revenue generation, it may stabilize and potentially return to profitability. Conversely, continued operational failures may lead to further financial distress, raising the specter of insolvency. The coming fiscal years will be crucial in determining whether Dharani Sugars can navigate these challenges effectively or succumb to its financial woes.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 95.3 Cr. | 24.8 | 784/24.1 | 0.93 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,655 Cr. | 165 | 212/124 | 118 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 45.0 Cr. | 3.53 | 8.19/3.42 | 4.93 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,447.32 Cr | 214.46 | 367.00 | 219.27 | 0.26% | 11.73% | 22.92% | 9.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Expenses | 2 | 3 | 3 | 2 | 1 | 1 | 2 | 3 | 6 | 5 | 8 | 6 | 6 |
| Operating Profit | -2 | -3 | -2 | -2 | -1 | -1 | -2 | -3 | -5 | -5 | -8 | -5 | -4 |
| OPM % | -228% | -4,975% | -7,575% | -1,904% | -2,223% | -4,500% | -2,387% | -243% | |||||
| Other Income | 0 | 0 | 0 | 0 | 0 | 120 | 36 | 1 | -8 | -0 | -1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 7 | 8 | 20 | 10 | 10 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | -8 | -8 | -7 | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 | -20 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -8 | -8 | -7 | -7 | -7 | 113 | 23 | -13 | -26 | -19 | -35 | -21 | -20 |
| EPS in Rs | -2.34 | -2.45 | -2.23 | -2.23 | -2.06 | 33.97 | 6.87 | -4.05 | -7.82 | -5.67 | -10.48 | -6.20 | -5.95 |
Last Updated: January 1, 2026, 11:02 pm
Below is a detailed analysis of the quarterly data for Dharani Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Jun 2025) to 2.00 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is -4.00 Cr.. The value appears strong and on an upward trend. It has increased from -5.00 Cr. (Jun 2025) to -4.00 Cr., marking an increase of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is -243.00%. The value appears strong and on an upward trend. It has increased from -2,387.00% (Jun 2025) to -243.00%, marking an increase of 2,144.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 10.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is -20.00 Cr.. The value appears strong and on an upward trend. It has increased from -21.00 Cr. (Jun 2025) to -20.00 Cr., marking an increase of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -20.00 Cr.. The value appears strong and on an upward trend. It has increased from -21.00 Cr. (Jun 2025) to -20.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is -5.95. The value appears strong and on an upward trend. It has increased from -6.20 (Jun 2025) to -5.95, marking an increase of 0.25.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 524 | 364 | 364 | 509 | 482 | 316 | 110 | 31 | 40 | 1 | 0 | 0 | 2 |
| Expenses | 475 | 374 | 324 | 435 | 482 | 353 | 154 | 49 | 57 | 10 | 7 | 22 | 25 |
| Operating Profit | 49 | -11 | 40 | 74 | -0 | -37 | -44 | -18 | -18 | -9 | -7 | -22 | -22 |
| OPM % | 9% | -3% | 11% | 15% | -0% | -12% | -40% | -59% | -45% | -1,127% | -3,561% | -2,903% | -937% |
| Other Income | 2 | 18 | 9 | 8 | 17 | 4 | 35 | 6 | 1 | 0 | 156 | -7 | -2 |
| Interest | 65 | 66 | 68 | 75 | 79 | 75 | 2 | 2 | 0 | 0 | 6 | 42 | 48 |
| Depreciation | 29 | 21 | 23 | 23 | 23 | 23 | 22 | 23 | 23 | 22 | 22 | 22 | 22 |
| Profit before tax | -43 | -81 | -43 | -16 | -85 | -131 | -33 | -38 | -40 | -31 | 121 | -93 | -94 |
| Tax % | -21% | -8% | -72% | 12% | 1% | 14% | -10% | 0% | 0% | 0% | 0% | 0% | |
| Net Profit | -34 | -74 | -12 | -17 | -85 | -149 | -30 | -38 | -40 | -31 | 121 | -93 | -94 |
| EPS in Rs | -11.50 | -25.23 | -4.08 | -5.25 | -25.72 | -44.98 | -9.00 | -11.46 | -12.11 | -9.45 | 36.54 | -28.01 | -28.30 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -117.65% | 83.78% | -41.67% | -400.00% | -75.29% | 79.87% | -26.67% | -5.26% | 22.50% | 490.32% | -176.86% |
| Change in YoY Net Profit Growth (%) | 0.00% | 201.43% | -125.45% | -358.33% | 324.71% | 155.16% | -106.53% | 21.40% | 27.76% | 467.82% | -667.18% |
Dharani Sugars & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 1025% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | -7% |
| 3 Years: | % |
| TTM: | -117% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 12% |
| 3 Years: | -9% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 2:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:10 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 29 | 29 | 29 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 42 | 42 |
| Reserves | 63 | -11 | 158 | 141 | 57 | -92 | -122 | -160 | -200 | -230 | -109 | -205 | -245 |
| Borrowings | 556 | 588 | 611 | 620 | 559 | 518 | 512 | 536 | 533 | 539 | 419 | 489 | 409 |
| Other Liabilities | 184 | 184 | 185 | 165 | 208 | 236 | 180 | 158 | 169 | 176 | 150 | 146 | 259 |
| Total Liabilities | 832 | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 | 464 |
| Fixed Assets | 477 | 462 | 629 | 610 | 604 | 583 | 558 | 538 | 514 | 492 | 470 | 448 | 436 |
| CWIP | 10 | 13 | 16 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 5 | 24 | 26 | 29 | 17 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
| Other Assets | 340 | 310 | 313 | 305 | 224 | 95 | 30 | 15 | 7 | 11 | 8 | 9 | 14 |
| Total Assets | 832 | 790 | 982 | 959 | 857 | 694 | 603 | 568 | 536 | 518 | 493 | 471 | 464 |
Below is a detailed analysis of the balance sheet data for Dharani Sugars & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 42.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 42.00 Cr..
- For Reserves, as of Sep 2025, the value is -245.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -205.00 Cr. (Mar 2025) to -245.00 Cr., marking a decline of 40.00 Cr..
- For Borrowings, as of Sep 2025, the value is 409.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 489.00 Cr. (Mar 2025) to 409.00 Cr., marking a decrease of 80.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 259.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 146.00 Cr. (Mar 2025) to 259.00 Cr., marking an increase of 113.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 464.00 Cr.. The value appears to be improving (decreasing). It has decreased from 471.00 Cr. (Mar 2025) to 464.00 Cr., marking a decrease of 7.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 436.00 Cr.. The value appears to be declining and may need further review. It has decreased from 448.00 Cr. (Mar 2025) to 436.00 Cr., marking a decrease of 12.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Other Assets, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 9.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 464.00 Cr.. The value appears to be declining and may need further review. It has decreased from 471.00 Cr. (Mar 2025) to 464.00 Cr., marking a decrease of 7.00 Cr..
However, the Borrowings (409.00 Cr.) are higher than the Reserves (-245.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -507.00 | -599.00 | -571.00 | -546.00 | -559.00 | -555.00 | -556.00 | -554.00 | -551.00 | -548.00 | -426.00 | -511.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 43 | 55 | 40 | 35 | 49 | 57 | 60 | 42 | 2,008 | ||
| Inventory Days | 235 | 246 | 335 | 226 | 133 | 32 | 25 | 28 | 7 | |||
| Days Payable | 101 | 154 | 187 | 77 | 114 | 140 | 400 | 1,263 | 954 | |||
| Cash Conversion Cycle | 149 | 134 | 203 | 190 | 53 | -59 | -318 | -1,175 | -906 | 2,008 | ||
| Working Capital Days | -76 | -97 | -97 | -132 | -245 | -565 | -2,142 | -7,763 | -6,175 | -302,768 | ||
| ROCE % | 3% | -2% | 4% | 7% | -1% | -11% | -15% | -9% | -10% | -9% | -8% | -13% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -24.60 | 36.54 | -9.44 | -12.11 | -11.46 |
| Diluted EPS (Rs.) | -24.60 | 36.54 | -9.44 | -12.11 | -11.46 |
| Cash EPS (Rs.) | -17.08 | 38.35 | -9.44 | -5.07 | -4.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -39.33 | -22.82 | -59.37 | -50.10 | -38.16 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -39.33 | -22.82 | -59.37 | -50.10 | -38.16 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.24 | 11.95 | 9.36 |
| PBDIT / Share (Rs.) | -5.03 | -1.93 | -2.74 | -5.06 | -3.77 |
| PBIT / Share (Rs.) | -10.36 | -3.73 | -2.74 | -12.10 | -10.82 |
| PBT / Share (Rs.) | -22.40 | 36.54 | -9.44 | -12.11 | -11.46 |
| Net Profit / Share (Rs.) | -22.40 | 36.54 | -9.44 | -12.11 | -11.46 |
| PBDIT Margin (%) | 0.00 | 0.00 | -1107.47 | -42.38 | -40.30 |
| PBIT Margin (%) | 0.00 | 0.00 | -1108.63 | -101.28 | -115.56 |
| PBT Margin (%) | 0.00 | 0.00 | -3817.05 | -101.32 | -122.34 |
| Net Profit Margin (%) | 0.00 | 0.00 | -3817.05 | -101.32 | -122.34 |
| Return on Networth / Equity (%) | 0.00 | -160.10 | 0.00 | 0.00 | 0.00 |
| Return on Capital Employeed (%) | -17.01 | -5.39 | 5.29 | 28.47 | 35.44 |
| Return On Assets (%) | -19.73 | 24.63 | -6.05 | -7.50 | -6.70 |
| Long Term Debt / Equity (X) | -2.21 | -3.78 | -0.03 | -0.03 | -0.04 |
| Total Debt / Equity (X) | -2.67 | -5.52 | -2.74 | -3.21 | -4.23 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 0.07 | 0.05 |
| Current Ratio (X) | 0.03 | 0.02 | 0.01 | 0.01 | 0.02 |
| Quick Ratio (X) | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | -0.01 | 27.52 | 6.52 |
| Interest Coverage Ratio (X) | -0.49 | -0.28 | -0.40 | -1355.96 | -5.94 |
| Interest Coverage Ratio (Post Tax) (X) | -1.03 | -0.55 | -0.40 | -3240.66 | -17.05 |
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 588.30 | 551.77 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 14.83 | 17.75 |
| EV / EBITDA (X) | 0.00 | 0.00 | 0.00 | -34.99 | -44.03 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 1.39 | 0.68 |
| Price / BV (X) | 0.00 | 0.00 | 0.00 | -0.33 | -0.16 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 1.39 | 0.68 |
| EarningsYield | 0.00 | 0.00 | 0.00 | -0.72 | -1.77 |
After reviewing the key financial ratios for Dharani Sugars & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -24.60. This value is below the healthy minimum of 5. It has decreased from 36.54 (Mar 24) to -24.60, marking a decrease of 61.14.
- For Diluted EPS (Rs.), as of Mar 25, the value is -24.60. This value is below the healthy minimum of 5. It has decreased from 36.54 (Mar 24) to -24.60, marking a decrease of 61.14.
- For Cash EPS (Rs.), as of Mar 25, the value is -17.08. This value is below the healthy minimum of 3. It has decreased from 38.35 (Mar 24) to -17.08, marking a decrease of 55.43.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -39.33. It has decreased from -22.82 (Mar 24) to -39.33, marking a decrease of 16.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -39.33. It has decreased from -22.82 (Mar 24) to -39.33, marking a decrease of 16.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -5.03. This value is below the healthy minimum of 2. It has decreased from -1.93 (Mar 24) to -5.03, marking a decrease of 3.10.
- For PBIT / Share (Rs.), as of Mar 25, the value is -10.36. This value is below the healthy minimum of 0. It has decreased from -3.73 (Mar 24) to -10.36, marking a decrease of 6.63.
- For PBT / Share (Rs.), as of Mar 25, the value is -22.40. This value is below the healthy minimum of 0. It has decreased from 36.54 (Mar 24) to -22.40, marking a decrease of 58.94.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -22.40. This value is below the healthy minimum of 2. It has decreased from 36.54 (Mar 24) to -22.40, marking a decrease of 58.94.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -160.10 (Mar 24) to 0.00, marking an increase of 160.10.
- For Return on Capital Employeed (%), as of Mar 25, the value is -17.01. This value is below the healthy minimum of 10. It has decreased from -5.39 (Mar 24) to -17.01, marking a decrease of 11.62.
- For Return On Assets (%), as of Mar 25, the value is -19.73. This value is below the healthy minimum of 5. It has decreased from 24.63 (Mar 24) to -19.73, marking a decrease of 44.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -2.21. This value is below the healthy minimum of 0.2. It has increased from -3.78 (Mar 24) to -2.21, marking an increase of 1.57.
- For Total Debt / Equity (X), as of Mar 25, the value is -2.67. This value is within the healthy range. It has increased from -5.52 (Mar 24) to -2.67, marking an increase of 2.85.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Current Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 1.5. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 1. It has increased from 0.02 (Mar 24) to 0.03, marking an increase of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -0.49. This value is below the healthy minimum of 3. It has decreased from -0.28 (Mar 24) to -0.49, marking a decrease of 0.21.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 3. It has decreased from -0.55 (Mar 24) to -1.03, marking a decrease of 0.48.
- For Enterprise Value (Cr.), as of Mar 25, the value is 0.00. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EV / EBITDA (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / BV (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.00.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dharani Sugars & Chemicals Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -17.01% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.03
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.03
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 367)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -2.67
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
Fundamental Analysis of Dharani Sugars & Chemicals Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Sugar | PGP House, New No. 59 Sterling Road, Chennai (Madras) Tamil Nadu 600034 | secretarial@dharanisugars-pgp.com http://www.dharanisugars.in |
| Management | |
|---|---|
| Name | Position Held |
| Dr. Palani G Periasamy | Executive Chairman |
| Mr. M Ramalingam | Managing Director |
| Mr. P S Gopalakrishnan | Independent Director |
| Mr. P Selvam | Independent Director |
| Dr. S Muthu | Independent Director |
| Dr. V R S Sampath | Independent Director |
| Mr. R K Viswanathan | Independent Director |
| Mr. A Sennimalai | Director |
| Mrs. Visalakshi Periasamy | Director |
| Dr. K C Reddy | Nominee Director |
Dharani Sugars & Chemicals Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹8.65 |
| Previous Day | ₹8.65 |
FAQ
What is the intrinsic value of Dharani Sugars & Chemicals Ltd?
Dharani Sugars & Chemicals Ltd's intrinsic value (as of 11 January 2026) is ₹112.55 which is 1216.37% higher the current market price of ₹8.55, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.4 Cr. market cap, FY2025-2026 high/low of ₹/, reserves of ₹-245 Cr, and liabilities of ₹464 Cr.
What is the Market Cap of Dharani Sugars & Chemicals Ltd?
The Market Cap of Dharani Sugars & Chemicals Ltd is 28.4 Cr..
What is the current Stock Price of Dharani Sugars & Chemicals Ltd as on 11 January 2026?
The current stock price of Dharani Sugars & Chemicals Ltd as on 11 January 2026 is ₹8.55.
What is the High / Low of Dharani Sugars & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Dharani Sugars & Chemicals Ltd stocks is ₹/.
What is the Stock P/E of Dharani Sugars & Chemicals Ltd?
The Stock P/E of Dharani Sugars & Chemicals Ltd is .
What is the Book Value of Dharani Sugars & Chemicals Ltd?
The Book Value of Dharani Sugars & Chemicals Ltd is 61.3.
What is the Dividend Yield of Dharani Sugars & Chemicals Ltd?
The Dividend Yield of Dharani Sugars & Chemicals Ltd is 0.00 %.
What is the ROCE of Dharani Sugars & Chemicals Ltd?
The ROCE of Dharani Sugars & Chemicals Ltd is 12.9 %.
What is the ROE of Dharani Sugars & Chemicals Ltd?
The ROE of Dharani Sugars & Chemicals Ltd is %.
What is the Face Value of Dharani Sugars & Chemicals Ltd?
The Face Value of Dharani Sugars & Chemicals Ltd is 10.0.